$DR.TO casually repurchased 6% of SO in a block trade at the end of May. The stock had its moment on fintwit a while ago, now I barely hear anyone mention it. Yet it's still executing, and it's still cheap

Medical Facilities Corporation Announces 2026 First Quarter Results prn.to/4uwhRQC | $DR.TO $MFCSF #buyback #NCIB #earnings #healthcare #TSX

$EVC Holy crap!

$EVC smashed it.

For myself Life is a bit like the stock market. In the short run, randomness dominates, people can treat you unfairly, and outcomes can be disconnected from effort. But over the long run, there’s a stronger pull toward deserved results on average. As late Munger put it “The world is not yet a crazy enough place to reward a whole bunch of undeserving people.”

Das beliebte Quartalsupdate steht an und getreu dem Motto "Never change a running system" ist auch Patrick Schmidt wieder mit dabei. Bei beiden Schmidts gab es einen verhaltenen Start ins Börsenjahr und Christian hat sich nach dem... youtube.com/watch?v=fqS1gebc…

Excited to share that the Special Situations Digest has moved to a new home. If you want a free month of paid access (Pro), just do the following: retweet this, drop a comment below, and send me a DM with your email, and I will give you complimentary access.

Before travelling to Stockholm, we also met with $CSU.TO Jamal Baksh. Just received the green light from him, so our report on our meeting will be published at the end of this week at tresorcapitalnieuws.nl. Be sure to subscribe (it's free!). We also discussed $TOI.V and $SABR, among others.

New Write up is out on $EVC, laying out the 10 similarities i see between $EVC today and $APP in June 2024 (which went on to be a 6 bagger within 12 months). I also framing the multi-bagger upside potential via adtech and spectrum.

$SABR receives plenty of hate. My timeline is full of people calling it a shitco. Investors who don’t understand $CSU.TO probably don’t get the $SABR story either. Yes, SABR may lag the market leader $AMADY and its biggest competitor. But almost all revenue is recurring — meaning profitability could be much higher than it is today. Many expenses could likely be cut without harming the top-line. Even a legacy business behind the leader could operate at similar margins as $AMADY for years. Imo, this is a cost-cutting story, not about making SABR the #1 GDS or airline IT business. Milk the cow and move on.

49% for Q4 and 61% FY. And excl. the whale client, ATS operating margin is still up ~350% year over year. This reaction is absurd. $EVC

Before someone reads “customer concentration from 🇨🇳” and immediately clicks sell, I think a few things are worth considering: 1/ What percentage of the company’s total revenue that concentration actually represents 2/ What kind of growth the AdTech segment and Smadex would have posted this year/quarter if $EVC hadn’t added that major customer 3/ Whether the market is actually pricing in high growth at the current valuation 4/ Where Smadex is headquartered, whether it sells a product or a service (or even whether the customer is actually Chinese or Hong Kong–based) 5/ What landing one large customer (the first of this profile for the AdTech segment) typically implies about the chances of landing another somewhere down the line It’s definitely not SaaS, but I also don’t think “not sticky” is a valid concern. Once a programmatic DSP onboards a client and establishes the relationship, the spend should be fairly recurring. Unless Smadex gets outcompeted on ROAS over time or customers stop valuing high level of support they currently receive. (which is another thing to consider) I don’t want to make an example out of @MallardResearch, but I’ve seen too many investors overblow this concern and miss the big picture not to comment on it.

Here's my take on $EVC's China risk. Mgmt noted one customer = 9% of group revenue in 3Q25 and FY25. Excluding them entirely, ATS still grew 49% y/y. Meanwhile Liftoff is eyeing an IPO at 27x EBIT on 32% growth with $1.85B in NIBD. Selloff seems completely overblown imo.

1/4 In der heutigen Folge befindet sich erstmals ein Gast direkt bei Christian vor Ort. @FBuschek war bereits schon einmal im Podcast vertreten und hat uns dieses Mal eine Aktie aus einem Sektor mitgebracht, der bislang noch gar nicht... open.spotify.com/episode/2jc…

ASSECO POLAND - TRANSAKCJE $ACP.WA Szacunkowa wartość: 14,988 mln

Model Portfolio Update: 77.88% Return Since Inception, 52.9% Annualized Return I will be giving away an annual subscription at random to an account that retweets this post.

$ACP.WA letter to shareholders inwestor.asseco.com/en/about…

$IRIX I just remembered a statement from the BI interview. Growth in 26 should be in the same range as the growth seen in Q4, which would imply revenue growth of roughly 15-17% for 26. This is not formal guidance, but it is still a promising indication. youtu.be/27bz1atjq6I?si=hDH0…

1/5 $IRIX At first glance, outstanding results, at least regarding growth in revenue and probes. It seems their efforts around probe growth are bearing fruit and are consistent with their recent comments in presentations. Regarding... app.tracktacle.com/publicati…

Every microcap multi-bagger is the result of a management team that strung together two or more great quarters in a row. Small stocks need momentum to reach escape velocity. The more quarters they string together the higher the stock goes. It's like dominos. Two great quarters in a row and the stock is probably a double. Three great quarters a triple. If a management can string together four to six great quarters and investors believe the momentum will continue - this is a 10-bagger. The hard truth is the momentum usually runs out before we think. Microcap companies reach a ceiling in leadership, opportunity or both. Only a select few can backfill appropriately with talent, processes, and execution to continue the momentum and reach new highs. microcapclub.com/how-long-wi…